AAPL349.73+1.51 (+0.43%) ▲|ABBV283.49-1.45 (-0.51%) ▼|ABT102.40-0.12 (-0.11%) ▼|ACN245.90-12.84 (-4.96%) ▼|ADBE266.96-3.59 (-1.33%) ▼|AMAT376.93+1.35 (+0.36%) ▲|AMD516.69+8.76 (+1.72%) ▲|AMGN440.77-6.51 (-1.46%) ▼|AMT192.35+10.78 (+5.94%) ▲|AMZN248.56-1.82 (-0.73%) ▼|AVGO324.87+1.63 (+0.50%) ▲|AXP315.83-9.34 (-2.87%) ▼|BA185.04-2.51 (-1.34%) ▼|BAC50.68-0.40 (-0.78%) ▼|BKNG157.29-3.81 (-2.37%) ▼|BLK1,121.22-16.08 (-1.41%) ▼|BMY61.77-1.23 (-1.95%) ▼|BNY144.11-1.21 (-0.83%) ▼|BRK-B545.91-1.07 (-0.19%) ▼|C120.89-1.62 (-1.32%) ▼|CAT683.80-20.26 (-2.88%) ▼|CL94.85-2.55 (-2.61%) ▼|CMCSA22.81-0.03 (-0.13%) ▼|COF200.80-2.64 (-1.30%) ▼|COP150.53+4.90 (+3.36%) ▲|COST1,010.61-7.60 (-0.75%) ▼|CRM245.87-4.43 (-1.77%) ▼|CSCO105.68+0.79 (+0.75%) ▲|CVS93.66-0.82 (-0.87%) ▼|CVX230.56+3.88 (+1.71%) ▲|DE635.53-8.10 (-1.26%) ▼|DHR226.74-3.01 (-1.31%) ▼|DIS112.11-1.02 (-0.90%) ▼|DUK124.40-1.01 (-0.80%) ▼|EMR158.70-1.59 (-0.99%) ▼|FDX296.83-7.10 (-2.33%) ▼|GD346.85-3.95 (-1.12%) ▼|GE284.21-9.33 (-3.18%) ▼|GEV807.01-20.41 (-2.47%) ▼|GILD156.36-0.84 (-0.53%) ▼|GM75.19-2.02 (-2.62%) ▼|GOOG320.81+0.05 (+0.01%) ▲|GOOGL323.99-0.23 (-0.07%) ▼|GS882.41-8.89 (-1.00%) ▼|HD319.03-8.70 (-2.65%) ▼|HON212.59-5.72 (-2.62%) ▼|IBM252.08-0.03 (-0.01%) ▼|INTC86.50+1.01 (+1.18%) ▲|INTU349.29-5.62 (-1.58%) ▼|ISRG452.05+8.20 (+1.85%) ▲|JNJ263.59-4.03 (-1.50%) ▼|JPM331.33-5.21 (-1.55%) ▼|KO93.27-2.08 (-2.18%) ▼|LIN505.84-4.52 (-0.89%) ▼|LLY1,277.92-28.77 (-2.20%) ▼|LMT593.98+4.07 (+0.69%) ▲|LOW198.83-5.55 (-2.71%) ▼|LRCX227.65-2.51 (-1.09%) ▼|MA623.08-10.14 (-1.60%) ▼|MCD248.54-4.09 (-1.62%) ▼|MDLZ63.93-1.26 (-1.93%) ▼|MDT95.79-0.80 (-0.83%) ▼|META644.37-4.48 (-0.69%) ▼|MMM170.98-4.58 (-2.61%) ▼|MO75.18-0.89 (-1.17%) ▼|MRK144.14-3.10 (-2.10%) ▼|MS181.46-2.52 (-1.37%) ▼|MSFT523.07+1.99 (+0.38%) ▲|MU881.87+25.38 (+2.96%) ▲|NEE81.43-0.48 (-0.58%) ▼|NFLX67.03-0.02 (-0.03%) ▼|NKE37.49-0.83 (-2.17%) ▼|NOW155.52-1.48 (-0.94%) ▼|NVDA212.66+0.45 (+0.21%) ▲|ORCL126.20+0.66 (+0.52%) ▲|PEP135.89-2.94 (-2.12%) ▼|PFE29.90-0.52 (-1.71%) ▼|PG162.04-2.46 (-1.50%) ▼|PLTR194.70-1.50 (-0.76%) ▼|PM201.34-0.40 (-0.20%) ▼|QCOM173.80+0.97 (+0.56%) ▲|RTX190.57-4.14 (-2.13%) ▼|SBUX101.23-0.68 (-0.67%) ▼|SCHW90.31-1.13 (-1.24%) ▼|SO93.14-0.69 (-0.73%) ▼|SPG211.43-0.61 (-0.29%) ▼|T21.53-1.22 (-5.34%) ▼|TMO667.70-8.84 (-1.31%) ▼|TMUS152.48-6.32 (-3.98%) ▼|TSLA372.08-2.51 (-0.67%) ▼|TXN281.50+2.00 (+0.72%) ▲|UBER67.71-1.36 (-1.97%) ▼|UNH421.78-3.21 (-0.75%) ▼|UNP289.88-8.22 (-2.76%) ▼|UPS99.36-2.16 (-2.13%) ▼|USB59.13-0.89 (-1.48%) ▼|V407.29-7.05 (-1.70%) ▼|VZ43.92-1.28 (-2.83%) ▼|WFC82.00-1.01 (-1.22%) ▼|WMT120.23-0.89 (-0.73%) ▼|XOM181.49+3.26 (+1.83%) ▲|AAPL349.73+1.51 (+0.43%) ▲|ABBV283.49-1.45 (-0.51%) ▼|ABT102.40-0.12 (-0.11%) ▼|ACN245.90-12.84 (-4.96%) ▼|ADBE266.96-3.59 (-1.33%) ▼|AMAT376.93+1.35 (+0.36%) ▲|AMD516.69+8.76 (+1.72%) ▲|AMGN440.77-6.51 (-1.46%) ▼|AMT192.35+10.78 (+5.94%) ▲|AMZN248.56-1.82 (-0.73%) ▼|AVGO324.87+1.63 (+0.50%) ▲|AXP315.83-9.34 (-2.87%) ▼|BA185.04-2.51 (-1.34%) ▼|BAC50.68-0.40 (-0.78%) ▼|BKNG157.29-3.81 (-2.37%) ▼|BLK1,121.22-16.08 (-1.41%) ▼|BMY61.77-1.23 (-1.95%) ▼|BNY144.11-1.21 (-0.83%) ▼|BRK-B545.91-1.07 (-0.19%) ▼|C120.89-1.62 (-1.32%) ▼|CAT683.80-20.26 (-2.88%) ▼|CL94.85-2.55 (-2.61%) ▼|CMCSA22.81-0.03 (-0.13%) ▼|COF200.80-2.64 (-1.30%) ▼|COP150.53+4.90 (+3.36%) ▲|COST1,010.61-7.60 (-0.75%) ▼|CRM245.87-4.43 (-1.77%) ▼|CSCO105.68+0.79 (+0.75%) ▲|CVS93.66-0.82 (-0.87%) ▼|CVX230.56+3.88 (+1.71%) ▲|DE635.53-8.10 (-1.26%) ▼|DHR226.74-3.01 (-1.31%) ▼|DIS112.11-1.02 (-0.90%) ▼|DUK124.40-1.01 (-0.80%) ▼|EMR158.70-1.59 (-0.99%) ▼|FDX296.83-7.10 (-2.33%) ▼|GD346.85-3.95 (-1.12%) ▼|GE284.21-9.33 (-3.18%) ▼|GEV807.01-20.41 (-2.47%) ▼|GILD156.36-0.84 (-0.53%) ▼|GM75.19-2.02 (-2.62%) ▼|GOOG320.81+0.05 (+0.01%) ▲|GOOGL323.99-0.23 (-0.07%) ▼|GS882.41-8.89 (-1.00%) ▼|HD319.03-8.70 (-2.65%) ▼|HON212.59-5.72 (-2.62%) ▼|IBM252.08-0.03 (-0.01%) ▼|INTC86.50+1.01 (+1.18%) ▲|INTU349.29-5.62 (-1.58%) ▼|ISRG452.05+8.20 (+1.85%) ▲|JNJ263.59-4.03 (-1.50%) ▼|JPM331.33-5.21 (-1.55%) ▼|KO93.27-2.08 (-2.18%) ▼|LIN505.84-4.52 (-0.89%) ▼|LLY1,277.92-28.77 (-2.20%) ▼|LMT593.98+4.07 (+0.69%) ▲|LOW198.83-5.55 (-2.71%) ▼|LRCX227.65-2.51 (-1.09%) ▼|MA623.08-10.14 (-1.60%) ▼|MCD248.54-4.09 (-1.62%) ▼|MDLZ63.93-1.26 (-1.93%) ▼|MDT95.79-0.80 (-0.83%) ▼|META644.37-4.48 (-0.69%) ▼|MMM170.98-4.58 (-2.61%) ▼|MO75.18-0.89 (-1.17%) ▼|MRK144.14-3.10 (-2.10%) ▼|MS181.46-2.52 (-1.37%) ▼|MSFT523.07+1.99 (+0.38%) ▲|MU881.87+25.38 (+2.96%) ▲|NEE81.43-0.48 (-0.58%) ▼|NFLX67.03-0.02 (-0.03%) ▼|NKE37.49-0.83 (-2.17%) ▼|NOW155.52-1.48 (-0.94%) ▼|NVDA212.66+0.45 (+0.21%) ▲|ORCL126.20+0.66 (+0.52%) ▲|PEP135.89-2.94 (-2.12%) ▼|PFE29.90-0.52 (-1.71%) ▼|PG162.04-2.46 (-1.50%) ▼|PLTR194.70-1.50 (-0.76%) ▼|PM201.34-0.40 (-0.20%) ▼|QCOM173.80+0.97 (+0.56%) ▲|RTX190.57-4.14 (-2.13%) ▼|SBUX101.23-0.68 (-0.67%) ▼|SCHW90.31-1.13 (-1.24%) ▼|SO93.14-0.69 (-0.73%) ▼|SPG211.43-0.61 (-0.29%) ▼|T21.53-1.22 (-5.34%) ▼|TMO667.70-8.84 (-1.31%) ▼|TMUS152.48-6.32 (-3.98%) ▼|TSLA372.08-2.51 (-0.67%) ▼|TXN281.50+2.00 (+0.72%) ▲|UBER67.71-1.36 (-1.97%) ▼|UNH421.78-3.21 (-0.75%) ▼|UNP289.88-8.22 (-2.76%) ▼|UPS99.36-2.16 (-2.13%) ▼|USB59.13-0.89 (-1.48%) ▼|V407.29-7.05 (-1.70%) ▼|VZ43.92-1.28 (-2.83%) ▼|WFC82.00-1.01 (-1.22%) ▼|WMT120.23-0.89 (-0.73%) ▼|XOM181.49+3.26 (+1.83%) ▲|
10.7 C
New York
Friday, October 23, 2026

Tag: food

newsFORsourcecompanycontentinformation1releasesmarket

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm...

NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients...

IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial

WePlay Teams Up with Popular IP “NaiLoong” for a Triple Treat Summer Fiesta

JAKARTA, Indonesia, Aug. 10, 2025 /PRNewswire/ -- WePlay, a globally leading social entertainment platform, today officially announced a major collaboration with the phenomenal IP, "NaiLoong"!...

Empower Your Portfolio: Top Growth Stock Picks for Women Investing $1,000

Hey there, money mavens! 🌟 Let's talk about making smart investments, especially in the world of dividend stocks. Picture this: you're sipping a refreshing...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. – UNCY

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE – ARGX

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  argenx SE (“argenx” or the “Company”) (NASDAQ: ARGX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. – DYN

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Dyne Therapeutics, Inc. (“Dyne” or the “Company”) (NASDAQ: DYN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. – EWTX

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. (“Edgewise” or the “Company”) (NASDAQ: EWTX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

KeySlim Drops Explores Ingredient-First Weight Management Trends in 2025

A Science-Backed Look at How KeySlim Drops’ Natural Formula Aligns With Evolving Healthy Weight Goals 
A Science-Backed Look at How KeySlim Drops’ Natural Formula Aligns With Evolving Healthy Weight Goals

GLP-1 Plus by Advanced BioNutritionals: 2025 DHB Breakthrough Ignites Interest in Non-Injection Hunger and Weight Trends

GLP-1 Plus by Advanced BioNutritionals enters the spotlight with a patented dihydroberberine (DHB) formula in 2025, reflecting rising interest in GLP-1 alternatives and non-injection hunger support solutions. 
GLP-1 Plus by Advanced BioNutritionals enters the spotlight with a patented dihydroberberine (DHB) formula in 2025, reflecting rising interest in GLP-1 alternatives and non-injection hunger support solutions.

Best Work Gloves (2025): Magid Glove & Safety Named Top Safety Work Gloves in Report by Expert Consumers

NEW YORK, Aug. 9, 2025 /PRNewswire/ -- Expert Consumers has named Magid as the top provider of safety work gloves in its recently released report....

Folqs Highlights First-Day, Grass-Fed Colostrum Powder Amid Global Surge in Demand

Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Folqs, a U.S.-based wellness company, introduces new consumer product, Folqs First-Day Colostrum Powder. This positions the company within the growing colostrum supplement sector, which has recently exceeded $3 billion in global market value, according to industry research.

Public health notice: Outbreak of Salmonella infections linked to various brands of pistachios and pistachio-containing products

August 8, 2025: Update OTTAWA, ON, Aug. 8, 2025 /CNW/ - This outbreak investigation is ongoing. The public health notice will be updated as the investigation...

OVER $2,000 IN PRIZES AT STASH’S FIRST-EVER “STASH SMASH” TOURNAMENT & TASTING PARTY

Presented by Bloom, Kaviar, and WyldFriday, August 15, 2025 | 4:20 PM – 8:00 PM | Orland Hills, IL ORLAND HILLS, Ill., Aug. 8, 2025...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFood

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers